BDSX - Biodesix GAAP EPS of -$0.49 in-line revenue of $7.22M beats by $0.02M
Biodesix press release (NASDAQ:BDSX): Q4 GAAP EPS of -$0.49 in-line. Revenue of $7.22M (-73.3% Y/Y) beats by $0.02M. 2022 Financial Outlook: The Company anticipates generating between $37.5 million to $39.5 million in total revenue in 2022 vs consensus of $36.38M.
For further details see:
Biodesix GAAP EPS of -$0.49 in-line, revenue of $7.22M beats by $0.02M